A denileukin diftitox (Ontak) associated retinopathy?
- 13 April 2006
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (8) , 1070-1071
- https://doi.org/10.1136/bjo.2006.091165
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2Frontiers in Bioscience-Landmark, 2006
- Clinical and Electrophysiologic Characterization of Paraneoplastic and Autoimmune Retinopathies Associated With Antienolase AntibodiesAmerican Journal of Ophthalmology, 2005
- Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathyBMC Ophthalmology, 2004
- Immune Responses to Retinal Self-Antigens in CD25+CD4+Regulatory T-Cell–Depleted MiceInvestigative Opthalmology & Visual Science, 2004
- Confirmation of the Activity of the Interleukin-2 Fusion Toxin Denileukin Diftitox against Chemorefractory Chronic Lymphocytic Leukemia, including Cases with Chromosome 17p Deletions and without Detectable CD25 ExpressionClinical Cancer Research, 2004
- Waldenström's macroglobulinemia–associated retinopathyOphthalmology, 2004
- Lymphoma-associated retinopathyOphthalmology, 2002
- Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell LymphomaJournal of Clinical Oncology, 2001